Latest Regulatory News

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

APC Minerals Limited has raised $264,000 through a discounted top-up placement of 66 million shares, enhancing its financial capacity to pursue new and existing projects.

Bass Oil reported steady December production with a notable gas sales agreement for the Vanessa field, signaling a strategic shift towards gas commercialization.

Dalaroo Metals’ maiden sampling at Blue Lagoon reveals a district-scale critical minerals system with high-grade zirconium, hafnium, and rare earth elements over a 2.7km strike. The results validate historical data and position the project as a strategic asset in Greenland’s emerging critical minerals landscape.

Tanami Gold NL has released final assay results from its 2025 drilling campaigns at the Jims Gold Mine and Defa Prospect, confirming extensive gold mineralisation and promising high-grade zones that could underpin future mining development.

1414 Degrees secures critical approvals from AEMO and ElectraNet for its 140 MW Aurora Battery Energy Storage System, advancing the project toward grid connection and commercial operation in 2026.

NobleOak Life Limited has increased its stamp duty provision to $6.5 million following a dispute with the Victorian State Revenue Office over exemption eligibility, prompting pricing changes and ongoing regulatory engagement.

Austral Resources Australia Ltd has agreed to acquire the Lady Loretta mine from Glencore for A$45.5 million, consolidating its copper assets near the Lady Annie Copper Mine and boosting its processing feedstock. This strategic move strengthens Austral’s balance sheet and advances its vision to become a mid-tier copper producer in Queensland.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Ausgold Limited has delivered an updated Definitive Feasibility Study for its Katanning Gold Project, revealing increased gold production and enhanced financial returns, supported by a $90 million capital raise to accelerate development.

Proteomics International has been granted a Canadian patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma. This milestone strengthens its global intellectual property portfolio and paves the way for commercial expansion in North America.